Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Neuro Oncology is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Patient rehabilitation Engineering & Materials Science
Glioblastoma Medicine & Life Sciences
Rehabilitation Medicine & Life Sciences
Feasibility Studies Medicine & Life Sciences
Nursing Engineering & Materials Science
Arm Medicine & Life Sciences
Dendritic Cells Medicine & Life Sciences
Upper Extremity Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1978 2019

  • 544 Citations
  • 9 h-Index
  • 18 Article
  • 6 Conference contribution
  • 2 Comment/debate
  • 1 Editorial

A randomized double-blind placebo-controlled phase II trial of dendritic cell vaccine ICT-107 in newly diagnosed patients with glioblastoma

Wen, P. Y., Reardon, D. A., Armstrong, T. S., Phuphanich, S., Aiken, R. D., Landolfi, J. C., Curry, W. T., Zhu, J. J., Glantz, M., Peereboom, D. M., Markert, J. M., LaRocca, R., O'Rourke, D. M., Fink, K., Kim, L., Gruber, M., Lesser, G. J., Pan, E., Kesari, S., Muzikansky, A. & 3 others, Pinilla, C., Santos, R. G. & Yu, J. S., Oct 1 2019, In : Clinical Cancer Research. 25, 19, p. 5799-5807 9 p.

Rutgers, The State University

Research output: Contribution to journalArticle

Glioblastoma
Dendritic Cells
Vaccines
Placebos
HLA-A2 Antigen
1 Citation (Scopus)

Correction: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma [J Transl Med., 16, (2018) (142)] DOI: 10.1186/s12967-018-1507-6

Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D'Andre, S. D., Iwamoto, F. M., Dropcho, E. J., Moshel, Y. A., Walter, K. A., Pillainayagam, C. P., Aiken, R., Chaudhary, R., Goldlust, S. A., Bota, D. A., Duic, P. & 49 others, Grewal, J., Elinzano, H., Toms, S. A., Lillehei, K. O., Mikkelsen, T., Walbert, T., Abram, S. R., Brenner, A. J., Brem, S., Ewend, M. G., Khagi, S., Portnow, J., Kim, L. J., Loudon, W. G., Thompson, R. C., Avigan, D. E., Fink, K. L., Geoffroy, F. J., Lindhorst, S., Lutzky, J., Sloan, A. E., Schackert, G., Krex, D., Meisel, H. J., Wu, J., Davis, R. P., Duma, C., Etame, A. B., Mathieu, D., Kesari, S., Piccioni, D., Westphal, M., Baskin, D. S., New, P. Z., Lacroix, M., May, S. A., Pluard, T. J., Tse, V., Green, R. M., Villano, J. L., Pearlman, M., Petrecca, K., Schulder, M., Taylor, L. P., Maida, A. E., Prins, R. M., Cloughesy, T. F., Mulholland, P. & Bosch, M. L., Jun 29 2018, In : Journal of translational medicine. 16, 1, 179.

Rutgers, The State University

Research output: Contribution to journalComment/debate

Phase III Clinical Trials
Glioblastoma
Dendritic Cells
Names
Vaccines
48 Citations (Scopus)

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma

Liau, L. M., Ashkan, K., Tran, D. D., Campian, J. L., Trusheim, J. E., Cobbs, C. S., Heth, J. A., Salacz, M., Taylor, S., D'Andre, S. D., Iwamoto, F. M., Dropcho, E. J., Moshel, Y. A., Walter, K. A., Pillainayagam, C. P., Aiken, R., Chaudhary, R., Goldlust, S. A., Bota, D. A., Duic, P. & 49 others, Grewal, J., Elinzano, H., Toms, S. A., Lillehei, K. O., Mikkelsen, T., Walpert, T., Abram, S. R., Brenner, A. J., Brem, S., Ewend, M. G., Khagi, S., Portnow, J., Kim, L. J., Loudon, W. G., Thompson, R. C., Avigan, D. E., Fink, K. L., Geoffroy, F. J., Lindhorst, S., Lutzky, J., Sloan, A. E., Schackert, G., Krex, D., Meisel, H. J., Wu, J., Davis, R. P., Duma, C., Etame, A. B., Mathieu, D., Kesari, S., Piccioni, D., Westphal, M., Baskin, D. S., New, P. Z., Lacroix, M., May, S. A., Pluard, T. J., Tse, V., Green, R. M., Villano, J. L., Pearlman, M., Petrecca, K., Schulder, M., Taylor, L. P., Maida, A. E., Prins, R. M., Cloughesy, T. F., Mulholland, P. & Bosch, M. L., May 29 2018, In : Journal of translational medicine. 16, 1, 1 p., 142.

Rutgers, The State University

Research output: Contribution to journalArticle

Phase III Clinical Trials
Glioblastoma
temozolomide
Dendritic Cells
Vaccines